If you are in tech, First revenues, then profits my friend... amazon and Facebook etc
Key takeaways:
1) USA ACV revenues $8.5 milion = breakeven/small profit, any further revenue growth from now at gross profit margins (~80%)
2) AUS ACV revenues $43.5 million = very high profit margins
USA revenue growth at 100% and AUS growth at 27% ... all R&D and fixed costs are now covered, so al revenue at NEA gross profit margins from operations at 80% ... plus we been spending a lot on new product features on 3D which is ready by Fall means even larger revenue growth.
1 year lookout at current revenue Growth to profit growth translation = $15.3m growth in net profits for 2018 calendar year (on top of Australian profit)
Derived from following incremental profit growth from current revenue trending
USA = $6 million profit (assuming all USA costs now covered)
AUS = $9.3m profit
Question now is what is AUS current profitability that we can add $15.3m profit to in order to derive P/E?
If 3D uptake higher than bobs your uncle, and we could closer to euphoria then with NEA share price doubling from what it is now releively easily.
- Forums
- ASX - By Stock
- NEA
- Ann: H1 FY2018 Preliminary Results - Record Growth
Ann: H1 FY2018 Preliminary Results - Record Growth, page-15
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online